Surging China Coronavirus Trials Prompt Tougher Criteria
Recruitment Challenges For Promising Drugs
Executive Summary
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.